open access

Vol 17, No 1 (2010)
Original articles
Published online: 2010-01-26
Submitted: 2013-01-14
Get Citation

Effect of milrinone on short-term outcome of patients with myocardial dysfunction undergoing coronary artery bypass graft: A randomized controlled trial

Mohammad Jebeli, Mohammad Ghazinoor, Mohammad Hussein Mandegar, Mohammad R. Rasouli, Payam Eghtesadi-Araghi, Hamidreza Goodarzynejad, Robabeh Mohammadzadeh, Ali Darehzereshki, Saied Dianat
Cardiol J 2010;17(1):73-78.

open access

Vol 17, No 1 (2010)
Original articles
Published online: 2010-01-26
Submitted: 2013-01-14

Abstract


Background: Myocardial dysfunction needing inotropic support is a typical complication after on-pump cardiac surgery. In this study, we evaluate the effect of milrinone on patients with ventricular dysfunction undergoing coronary artery bypass graft (CABG).
Methods: Seventy patients with impaired left ventricular function [left ventricular ejection fraction (LVEF) < 35%] undergoing on-pump CABG were enrolled. Patients were randomized to receive either an intraoperative bolus of milrinone (50 μg/kg) or saline as placebo followed by a 24-hour infusion of each agent (0.5 μg/kg/min). Hemodynamic parameters and transthoracic echocardiographic measurement of systolic and diastolic functions were the variables evaluated.
Results: Serum levels of creatine phosphokinase (CPK), the MB isoenzyme of creatine kinase (CK-MB), occurrence of myocardial ischemia or infarction, and mean duration of using inotropic agents were significantly lower in the milrinone group (p < 0.05). There were no significant differences between the two groups regarding the development of ventricular arrhythmia, duration of cardiopulmonary bypass, intra-aortic balloon pump and inotropic support requirement, duration of mechanical ventilation, duration of intensive care unit stay and mortality rate. Although mean pre-operative LVEF was significantly lower in the milrinone group, there was no significant difference between post-operative LVEFs.
Conclusions: We suggest that perioperative administration of milrinone in patients undergoing on-pump CABG, especially those with low LVEF, is beneficial.
(Cardiol J 2010; 17, 1: 73-78)

Abstract


Background: Myocardial dysfunction needing inotropic support is a typical complication after on-pump cardiac surgery. In this study, we evaluate the effect of milrinone on patients with ventricular dysfunction undergoing coronary artery bypass graft (CABG).
Methods: Seventy patients with impaired left ventricular function [left ventricular ejection fraction (LVEF) < 35%] undergoing on-pump CABG were enrolled. Patients were randomized to receive either an intraoperative bolus of milrinone (50 μg/kg) or saline as placebo followed by a 24-hour infusion of each agent (0.5 μg/kg/min). Hemodynamic parameters and transthoracic echocardiographic measurement of systolic and diastolic functions were the variables evaluated.
Results: Serum levels of creatine phosphokinase (CPK), the MB isoenzyme of creatine kinase (CK-MB), occurrence of myocardial ischemia or infarction, and mean duration of using inotropic agents were significantly lower in the milrinone group (p < 0.05). There were no significant differences between the two groups regarding the development of ventricular arrhythmia, duration of cardiopulmonary bypass, intra-aortic balloon pump and inotropic support requirement, duration of mechanical ventilation, duration of intensive care unit stay and mortality rate. Although mean pre-operative LVEF was significantly lower in the milrinone group, there was no significant difference between post-operative LVEFs.
Conclusions: We suggest that perioperative administration of milrinone in patients undergoing on-pump CABG, especially those with low LVEF, is beneficial.
(Cardiol J 2010; 17, 1: 73-78)
Get Citation

Keywords

on-pump coronary artery bypass graft; low output syndrome; left ventricular dysfunction; milrinone; low left ventricular ejection fraction

About this article
Title

Effect of milrinone on short-term outcome of patients with myocardial dysfunction undergoing coronary artery bypass graft: A randomized controlled trial

Journal

Cardiology Journal

Issue

Vol 17, No 1 (2010)

Pages

73-78

Published online

2010-01-26

Bibliographic record

Cardiol J 2010;17(1):73-78.

Keywords

on-pump coronary artery bypass graft
low output syndrome
left ventricular dysfunction
milrinone
low left ventricular ejection fraction

Authors

Mohammad Jebeli
Mohammad Ghazinoor
Mohammad Hussein Mandegar
Mohammad R. Rasouli
Payam Eghtesadi-Araghi
Hamidreza Goodarzynejad
Robabeh Mohammadzadeh
Ali Darehzereshki
Saied Dianat

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl